Russia Approves Second Covid-19 Vaccine Before Phase 3 Trial
Ampoules containing a component of the ‘Gam-COVID-Vac’ Covid-19 vaccine, developed by Russia. (Photographer: Andrey Rudakov/Bloomberg)

Russia Approves Second Covid-19 Vaccine Before Phase 3 Trial

(Bloomberg) -- Russian health authorities approved a Covid-19 vaccine created by a former biological weapons research laboratory for public use, marking the second time the Kremlin has bypassed acc...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.